XML 43 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Common Stock and Stock Plans (Tables)
12 Months Ended
Mar. 31, 2022
Equity [Abstract]  
Summary of Stock-based Compensation Expense

Total stock-based compensation expense recognized in accordance with the authoritative guidance for share-based payments was as follows:

 

 

 

Fiscal Years Ended

 

 

 

March 31, 2022

 

 

March 31, 2021

 

 

March 31, 2020

 

 

 

(In thousands)

 

Stock-based compensation expense before taxes

 

$

86,808

 

 

$

84,879

 

 

$

86,553

 

Related income tax benefits

 

 

(20,228

)

 

 

(19,485

)

 

 

(20,388

)

Stock-based compensation expense, net of taxes

 

$

66,580

 

 

$

65,394

 

 

$

66,165

 

Summary of Employee Stock Options and Employee Stock Purchase Plan Weighted Average Assumptions The weighted average assumptions (annualized percentages) used in the Black-Scholes model and Monte Carlo simulation were as follows:

 

 

 

Stock Options

 

 

TSR Performance Stock Options

 

 

Employee Stock Purchase Plan

 

 

 

Fiscal Year
2022

 

 

Fiscal Year
2021

 

 

Fiscal Year
2020

 

 

Fiscal Year
2022

 

 

Fiscal Year
2021

 

 

Fiscal Year
2020

 

 

Fiscal Year
2022

 

 

Fiscal Year
2021

 

 

Fiscal Year
2020

 

Volatility

 

 

49.5

%

 

 

39.1

%

 

 

27.9

%

 

 

42.5

%

 

 

39.8

%

 

 

27.7

%

 

 

42.1

%

 

 

64.8

%

 

 

24.6

%

Risk-free interest rate

 

 

0.4

%

 

 

0.2

%

 

 

1.3

%

 

 

1.2

%

 

 

0.4

%

 

 

1.7

%

 

 

0.1

%

 

 

0.1

%

 

 

1.8

%

Dividend yield

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

Expected life

 

3.2 years

 

 

5.0 years

 

 

5.0 years

 

 

5.0 years

 

 

5.0 years

 

 

5.0 years

 

 

0.5 years

 

 

0.5 years

 

 

0.5 years

 

Summary of Stock Option Activity and TSR Performance Stock Option Activity

A summary of stock option activity for fiscal year 2022 is presented below:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise Price
per Share

 

 

Weighted Average
Remaining
Contractual
Term in Years

 

 

Aggregate
Intrinsic
Value
(In thousands)

 

Outstanding at March 31, 2021

 

 

956,733

 

 

$

65.18

 

 

 

 

 

 

 

Options granted

 

 

99,222

 

 

 

79.41

 

 

 

 

 

 

 

Options expired

 

 

(388,119

)

 

 

62.61

 

 

 

 

 

 

 

Options exercised

 

 

(27,107

)

 

 

56.33

 

 

 

 

 

 

 

Outstanding at March 31, 2022

 

 

640,729

 

 

$

69.32

 

 

 

1.6

 

 

$

483

 

Vested and exercisable at March 31, 2022

 

 

598,994

 

 

$

70.58

 

 

 

1.3

 

 

$

431

 

A summary of TSR performance stock option activity for fiscal year 2022 is presented below:

 

 

 

Number of
Shares (1)

 

 

Weighted
Average
Exercise Price
per Share

 

 

Weighted Average
Remaining
Contractual
Term in Years

 

 

Aggregate
Intrinsic
Value
(In thousands)

 

Outstanding at March 31, 2021

 

 

2,415,459

 

 

$

59.87

 

 

 

 

 

 

 

TSR performance options granted

 

 

599,292

 

 

 

53.43

 

 

 

 

 

 

 

TSR performance options canceled

 

 

(578,764

)

 

 

70.50

 

 

 

 

 

 

 

TSR performance options exercised

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2022

 

 

2,435,987

 

 

$

55.76

 

 

 

4.2

 

 

$

9,690

 

Vested and exercisable at March 31, 2022

 

 

 

 

$

 

 

 

 

 

$

 

 

(1)
Number of shares is based on the target number of options under each TSR performance stock option.
Summary of Restricted Stock Unit Activity A summary of restricted stock unit activity for fiscal year 2022 is presented below:

 

 

 

Number of
Restricted
Stock
Units

 

 

Weighted
Average Grant
Date Fair Value
per Share

 

Outstanding at March 31, 2021

 

 

3,431,561

 

 

$

53.44

 

Awarded

 

 

2,080,700

 

 

 

52.85

 

Forfeited

 

 

(217,024

)

 

 

52.93

 

Vested

 

 

(1,274,311

)

 

 

58.65

 

Outstanding at March 31, 2022

 

 

4,020,926

 

 

$

51.51

 

Vested and deferred at March 31, 2022

 

 

194,641

 

 

$

48.96